The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
could we hypothesize that relief from depression has something to do with neuroplasticity rewiring of neural circuits and that psilocybin we know can encourage neuroplasticity and that perhaps ssris can encourage neuroplasticity in some people not all and that inflammation is a barrier to neuroplasticity
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what role psychedelics may also play as immunomodulators even as a secondary effect particularly in light of what we know about the role of inflammation in the listening symptoms of depression